Osimertinib for Japanese patients with T790M‐positive advanced non‐small‐cell lung cancer: A pooled subgroup analysis

Epidermal growth factor receptor (EGFR)‐tyrosine kinase inhibitors (TKIs) are the standard of care for non‐small‐cell lung cancer (NSCLC) patients harboring EGFR mutations. However, almost all patients develop resistance after approximately 1 y of treatment, with >50% of cases due to the T790M se...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Sci
Main Authors: Hirashima, Tomonori, Satouchi, Miyako, Hida, Toyoaki, Nishio, Makoto, Kato, Terufumi, Sakai, Hiroshi, Imamura, Fumio, Kiura, Katsuyuki, Okamoto, Isamu, Kasahara, Kazuo, Uchida, Hirohiko, Vowler, Sarah L., Mitsudomi, Tetsuya
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2019
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6726692/
https://ncbi.nlm.nih.gov/pubmed/31265163
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.14120
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados